Renovis renovis.com


Public lists: Pharma Startups (4732)

Renovis is a biopharmaceutical company that seeks to improve the lives of patients suffering from neurological disease with novel drugs that renew, restore, and repair the nervous system. The Company is developing REN-1654, a Phase II drug for neuropathic pain, and REN-213, a drug for post-operative pain that will enter Phase I later in 2003. Renovis will be entitled to future milestones and royalties in connection with the successful development of Cerovive, which is in pivotal Phase III clinic...Show all

Renovis is a biopharmaceutical company that seeks to improve the lives of patients suffering from neurological disease with novel drugs that renew, restore, and repair the nervous system. The Company is developing REN-1654, a Phase II drug for neurop...Show all

Company (Acquired)

Phone: 650-266-1400

Fax: +1 510 601 5201

Two Corporate Drive

South San Francisco, 94080
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Renovis $171.1M May 9, 2008
See all 34 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Renovis Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 22 investors

Competitors

Company Status Description Investors

Alexza Pharmaceuticals

Mountain View, California, United States
AcquiredAlexza is developing drugs for acute and intermittent medical conditions. Their Staccato system aerosolizes without thermal degradation, enabling convenient delivery and rapid therapeutic onset of many small molecule drugs. The company has product candidates in clinical trials for migraine headaches, acute panic attacks, acute agitation in schizophrenia and acute pain.Login to see details

PlantForm Corporation

Guelph, Ontario, Canada
Alive / ActivePlantForm Corp is a new company focused on providing low cost therapeutic drugs for the improvement of quality of life. Established in early 2008 the company will use technology licensed from the University of Guelph to manufacture antibody and protein drugs in tobacco plants. The company's first product will be a biosimilar version of the breast cancer drug Herceptin. The world market in 2007 for this product was $1.7 billion and is anticipated to plateau at $3 billion in 2014 when PlantForm's ...Show allLogin to see details
See all 34 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Surgical implant devices incorporating porous surfaces Jul 24, 2014 Application